Chiara Laura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chiara Laura has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Matteo Iannacone
Institute of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
2 shared publications - Alessandro Sessa
Neuroepigenetics Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy
1 shared publication Ali Hashemi Gheinani
Functional Urology Research Group, Department for BioMedical Research DBMR, University of Bern, Bern, Switzerland
1 shared publicationCaroline Krüger
Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
1 shared publication- Chiara Perucchini
Institute of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
1 shared publication - Daniela Claudino Carvoeiro
Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland
1 shared publication
Latest Publications
- 30 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6797) , eadq2080
Lymphoid tissue chemokines limit priming duration to preserve CD8 + T cell functionality
The generation of effector CD8 + T cells (T EFF ) requires activation of naïve CCR7 + T cells (T N ) by dendritic cells (DCs) in lymphoid tissue. How T N -DC interaction duration and signal integration are controlled remains unclear. In this study, we show that lymphoid stroma–secreted CCR7 ligands limit interaction duration by progressively inducing CD8 + T cell release from DCs. At late interaction stages, CCR7 ligands relocalize the F-actin regulator DOCK2 away from the DC interface, permitting T cell detachment, proliferation onset, and acquisition of cytotoxicity. Disruption of CCR7 signaling causes prolonged T cell–DC contacts and produces dysfunctional T EFF with elevated inhibitory receptors, reduced antimicrobial activity, and impaired recall responses. Stromal chemokines therefore act as critical regulators of T cell priming by DCs, preserving CD8 + effector function during acute and memory phases.
- 30 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6797) , eadq2080
Lymphoid tissue chemokines limit priming duration to preserve CD8 + T cell functionality
The generation of effector CD8 + T cells (T EFF ) requires activation of naïve CCR7 + T cells (T N ) by dendritic cells (DCs) in lymphoid tissue. How T N -DC interaction duration and signal integration are controlled remains unclear. In this study, we show that lymphoid stroma–secreted CCR7 ligands limit interaction duration by progressively inducing CD8 + T cell release from DCs. At late interaction stages, CCR7 ligands relocalize the F-actin regulator DOCK2 away from the DC interface, permitting T cell detachment, proliferation onset, and acquisition of cytotoxicity. Disruption of CCR7 signaling causes prolonged T cell–DC contacts and produces dysfunctional T EFF with elevated inhibitory receptors, reduced antimicrobial activity, and impaired recall responses. Stromal chemokines therefore act as critical regulators of T cell priming by DCs, preserving CD8 + effector function during acute and memory phases.
- Open Access
- 28 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (67) , eabl9929
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion
The development of a tractable small animal model faithfully reproducing human coronavirus disease 2019 pathogenesis would arguably meet a pressing need in biomedical research. Thus far, most investigators have used transgenic mice expressing the human ACE2 in epithelial cells (K18-hACE2 transgenic mice) that are intranasally instilled with a liquid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suspension under deep anesthesia. Unfortunately, this experimental approach results in disproportionate high central nervous system infection leading to fatal encephalitis, which is rarely observed in humans and severely limits this model’s usefulness. Here, we describe the use of an inhalation tower system that allows exposure of unanesthetized mice to aerosolized virus under controlled conditions. Aerosol exposure of K18-hACE2 transgenic mice to SARS-CoV-2 resulted in robust viral replication in the respiratory tract, anosmia, and airway obstruction but did not lead to fatal viral neuroinvasion. When compared with intranasal inoculation, aerosol infection resulted in a more pronounced lung pathology including increased immune infiltration, fibrin deposition, and a transcriptional signature comparable to that observed in SARS-CoV-2–infected patients. This model may prove useful for studies of viral transmission, disease pathogenesis (including long-term consequences of SARS-CoV-2 infection), and therapeutic interventions.
- 28 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 7 (67) , eabl9929
Open AccessAdministration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion
The development of a tractable small animal model faithfully reproducing human coronavirus disease 2019 pathogenesis would arguably meet a pressing need in biomedical research. Thus far, most investigators have used transgenic mice expressing the human ACE2 in epithelial cells (K18-hACE2 transgenic mice) that are intranasally instilled with a liquid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suspension under deep anesthesia. Unfortunately, this experimental approach results in disproportionate high central nervous system infection leading to fatal encephalitis, which is rarely observed in humans and severely limits this model’s usefulness. Here, we describe the use of an inhalation tower system that allows exposure of unanesthetized mice to aerosolized virus under controlled conditions. Aerosol exposure of K18-hACE2 transgenic mice to SARS-CoV-2 resulted in robust viral replication in the respiratory tract, anosmia, and airway obstruction but did not lead to fatal viral neuroinvasion. When compared with intranasal inoculation, aerosol infection resulted in a more pronounced lung pathology including increased immune infiltration, fibrin deposition, and a transcriptional signature comparable to that observed in SARS-CoV-2–infected patients. This model may prove useful for studies of viral transmission, disease pathogenesis (including long-term consequences of SARS-CoV-2 infection), and therapeutic interventions.